Lantern Pharma (LTRN) Q3 2023 Earnings

8NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.48
-0.42
-0.35
-0.29

Details

Expected EPS
-0.45
Actual EPS
-0.29
Surprise EPS
0.16
Surprise Percent
+35.56%

Description

Lantern Pharma (LTRN) has reported earnings of -0.29 per share for Q3 2023.

0 Comments

Share your thoughts